Learn how experts optimally test for biomarkers in patients with NSCLC in this interactive text module with multidisciplinary perspectives from Matthew Gubens, MD, MS, a thoracic oncologist, and Craig Mackinnon, MD, PhD, an anatomical and molecular pathologist, and then use the results to integrate novel and emerging targeted therapies effectively and safely into clinical practice care.
Review this slideset on current recommendations for evidence-based biomarker testing to guide treatment decision-making for patients with NSCLC from Matthew Gubens, MD, MS, and Craig Mackinnon, MD, PhD.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.